Which ventilator setting saves more lungs? a Head-to-Head test
NCT ID NCT07741916
First seen Aug 03, 2026 · Last updated Aug 04, 2026 · Updated 1 time
Summary
This study compares different bedside methods for choosing the optimal ventilator pressure (PEEP) in patients with moderate-to-severe acute respiratory distress syndrome (ARDS). The goal is to see if these methods give similar results and which one best balances keeping lungs open while avoiding overstretching. Researchers will analyze data from 45 ICU patients on mechanical ventilation, measuring lung mechanics and oxygenation at various PEEP levels. The findings could help standardize how doctors set ventilator pressure for ARDS patients.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Different PEEP (positive end-expiratory pressure) levels set via various bedside assessment tools
- What this could lead to
- If successful, this could identify the most reliable bedside method to set ventilator pressure, potentially improving outcomes for ARDS patients.
- What could go wrong
- This is a small observational study, so results may not apply broadly. The methods may not be interchangeable, and no single approach may emerge as clearly superior.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 45 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Sep 2026
An estimate. Start dates often move.
- Expected to finish
-
Jan 2030
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients on invasive mechanical ventilation * With moderate-to-severe ARDS : 1. Bilateral findings on chest X-ray 2. PaO₂/FiO₂ ratio \<200 with PEEP ≥+5 cmH₂O 3. No evidence of cardiogenic pulmonary overload * Patients without inspiratory effort (curare administration not required) * Patient already fitted with an esophageal pressure probe * Patient already fitted with a thoracic impedance belt * No objection from the patient or a family member to the processing of their clinical data Exclusion Criteria: * Protected individuals, namely: 1. Individuals receiving enhanced protection, namely minors 2. Individuals deprived of their liberty by a judicial or administrative decision 3. Pregnant and breastfeeding women 4. Individuals residing in a health or social care facility 5. Adults under legal guardianship * Patients with a do-not-resuscitate order or a decision to limit care * Patients with a pacemaker or an implantable cardioverter-defibrillator * Acute cor pulmonale * Pneumothorax or ongoing pleural/thoracic drainage * Patients in the prone position * Hemodynamic instability 1. An increase of \>30% in the norepinephrine dosage over the past 6 hours 2. Norepinephrine dosage \> 0.5 µg/kg/min * Patients on veno-venous ECMO
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Acute respiratory distress syndrome are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
CHU de Nice
Nice, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can donated immune cells calm the cytokine storm?
- Steroid dose showdown: can more dexamethasone save lives in respiratory failure?
- Breathing machine settings put to the test in severe lung injury
- The hidden breath: how a mismatch between patient and machine may shape ARDS recovery
- Scientists hunt for hidden subgroups in sudden respiratory failure
- AI plus ultrasound could catch heart and lung decline before it turns critical